Alka Mallik, M.D.

Alka Mallik, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Hematology and Oncology. She specializes in lymphoma and lung, breast, and colon cancers.

Dr. Mallik holds a bachelor's degree in biological sciences with a minor in history from Stanford University in Stanford, California. She earned her medical degree at UT Southwestern, where she also completed internal medicine residency training. She then gained advanced training through a fellowship program in hematology and medical oncology at New York-Presbyterian/Weill Cornell Medical Center, where she served as Chief Fellow and also participated in translational research into lymphoma therapeutics in the Melnick Lab.

Certified by the American Board of Internal Medicine in hematology and medical oncology, she joined the UT Southwestern faculty in 2022.

Dr. Mallik’s clinical and primary research interests include malignant and benign hematology, including hemostasis and thrombosis. She has served as an investigator on several clinical trials, given lectures on internal medicine for residents and medical students, and published peer-reviewed academic articles related to her areas of expertise.

She is also dedicated to undergraduate and graduate medical education. 

Dr. Mallik is an active a member of the American Society of Clinical Oncology and the American Society of Hematology.

 

Personal Note

Outside of medicine, Dr. Mallik enjoys photography and travel. She is fluent in Hindi.

Medical School

UT Southwestern Medical School (2004)

Internship

UT Southwestern Medical Center (2005), Internal Medicine

Residency

UT Southwestern Medical Center (2007), Internal Medicine

Fellowship

New York Presbyterian Hospital - Weill Cornell Medical Center (2010), Hematology Oncology

• Breast cancer
• Colon Cancer
• Hematologic Malignancies (Leukemia, Lymphoma, Myeloma)
• Hemostasis and Thrombosis

Featured Publications

A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement.

Mallik A, Carlson KB, DeSancho MT Blood Coagul. Fibrinolysis 2011 Jan 22 1

Peri- and postoperative haematologic management in a patient with type 2 von Willebrand disease undergoing mitral valve replacement.

Arnason JE, Mallik A, De Sancho M Haemophilia 2011 Jan 17 1

Reality of complementary and alternative medicine in lymphoma patients: hope, hype, or help?

Mallik A, Leonard JP Am. J. Hematol. 2009 Dec 84 12

A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.

Cerchietti LC, Lopes EC, Yang SN, Hatzi K, Bunting KL, Tsikitas LA, Mallik A, Robles AI, Walling J, Varticovski L, Shaknovich R, Bhalla KN, Chiosis G, Melnick A Nat. Med. 2009 Dec 15 12

• Fellow Travel Grant
  National Comprehensive Cancer Network (2010)
• Chief Hematology and Medical Oncology Fellow
  Weill Cornell Medical Center/New York Presbyterian Hospital (2009)
• Fellow Travel Award
  Cancer and Leukemia Group B, Weill Cornell Medical College (2009)
• Fellows Research Award Finalist
  Weill Cornell Medical College (2009)
• Fellow Travel Award
  Cancer and Leukemia Group B, Weill Cornell Medical College (2008)
• Rolland Robbins Award for Academic Excellence
  UT Southwestern Medical Center (2004)

• American Society of Clinical Oncology
• American Society of Hematology